Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kevin Lin, M.D., Ph.D.

Concepts (101)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Kevin Lin's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Kevin Lin has written about over time.
bcl-X Protein, 4 publications between 2014 and 2019, average publication date June 2017. Proto-Oncogene Proteins c-bcl-2, 3 publications between 2014 and 2019, average publication date August 2017. MAP Kinase Signaling System, 2 publications between 2014 and 2020, average publication date September 2017. Sulfonamides, 3 publications between 2016 and 2019, average publication date January 2018. Drug Resistance, Neoplasm, 8 publications between 2014 and 2020, average publication date March 2018. Cell Line, Tumor, 9 publications between 2014 and 2021, average publication date August 2018. Antineoplastic Agents, 5 publications between 2015 and 2023, average publication date October 2018. Proto-Oncogene Proteins p21(ras), 2 publications between 2017 and 2020, average publication date January 2019. Heme, 1 publications between 2019 and 2019, average publication date February 2019. Proto-Oncogene Proteins c-akt, 3 publications between 2014 and 2022, average publication date April 2019. Leukemia, Myeloid, Acute, 3 publications between 2016 and 2022, average publication date April 2019. HEK293 Cells, 3 publications between 2018 and 2020, average publication date May 2019. Apoptosis, 6 publications between 2014 and 2023, average publication date July 2019. Genetic Pleiotropy, 1 publications between 2020 and 2020, average publication date March 2020. Oncogene Proteins v-abl, 1 publications between 2021 and 2021, average publication date October 2021. Karyopherins, 1 publications between 2022 and 2022, average publication date June 2022. Receptors, Purinergic P2Y2, 1 publications between 2022 and 2022, average publication date June 2022.

To see the data from this visualization as text, click here.
Lin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (101)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.